샘플 요청 목록

 카트 문의
시장보고서
상품코드
1439546

소화관 내시경 협착 관리 기기 : 세계 시장 인사이트, 경쟁 구도 및 시장 예측(2030년)

Gastrointestinal Endoscopic Stricture Management Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
발행일: | 리서치사: DelveInsight | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계 소화관 내시경 협착 관리 기기 시장은 2024-2030년의 예측 기간 동안 5.36%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 대장암, 직장암, 식도암, 위식도역류질환(GERD), 과민성대장증후군(IBS) 등 다양한 소화관(GI) 질환의 유병률 증가로 인해 소화관 내시경 협착 관리 기기에 대한 수요가 증가하고 있습니다. 또한 저침습적 치료 장비에 대한 수요 증가, 소화관 질환을 유발하는 위험 요인 증가, 노령 인구 증가, 장비 관련 기술 발전, 제품 승인 및 출시 증가 등이 2024-2030년의 예측 기간 동안 소화관 내시경 협착 관리 장비 시장의 전반적인 성장에 기여할 것으로 예상됩니다.

위장관 내시경 협착 관리 장비 시장 역학

GLOBOCAN(2021)에 따르면, 2020년 전 세계적으로 식도암은 약 60만 4,100건의 신규 사례가 보고됐습니다. 같은 자료에 따르면 2020년 전 세계적으로 위암은 109만 9,103건, 담도암은 11만 5,949건이 새로 보고됐습니다.

또한, 여러 연구에 따르면, 소화관 내시경 협착 관리 기기의 일종인 스텐트 삽입술이 식도, 위십이지장, 대장의 폐색 증상을 완화하는 데 매우 중요하다는 사실이 여러 연구에서 밝혀졌습니다. 따라서 자기 확장형 금속 스텐트(SEMS)의 내시경 삽입은 소화관(GIT)의 악성 폐색 및 협착을 관리하기 위한 최전방 응용 분야로, 시장 성장을 가속하고 있습니다.

또한, International Foundation for Gastrointestinal Disorders의 최신 조사에 따르면 전 세계 인구의 5-10%가 과민성 대장 증후군(IBS)을 앓고 있는 것으로 추정되며, IBS 환자의 대부분은 50세 미만인 것으로 나타났습니다. 입니다. 또한 IBS 환자 중 약 2명 중 1명은 여성, 약 3명 중 1명은 남성이며, IBS 유병률 증가는 협착 장애를 유발할 수 있으며, 이는 소화관 내시경 협착 관리 장비로 치료할 수 있습니다.

따라서 다양한 소화기 질환의 유병률 증가는 협착 손상으로 이어져 소화기 내시경 협착 관리 장비에 대한 수요를 증가시켜 예측 기간 동안 소화기 내시경 협착 관리 장비 시장을 견인할 것으로 보입니다.

또한, 스텐트 및 확장 장치는 소화관 벽을 효과적으로 확장하고 보호할 수 있습니다. 이러한 장비는 합병증 발생률이 낮고 기술적 성공률이 높기 때문에 환자의 삶의 질을 향상시킬 수 있습니다. 이러한 장비는 또한 침습적 시술의 유력한 대안으로 작용할 수 있습니다. 기존 수술에 비해 최소 침습 수술은 첨단 기술을 사용하여 작은 절개를 통해 내부 장기에 접근하기 때문에 통증이 적고, 감염 위험이 낮으며, 입원 기간이 짧고, 회복이 빠르며, 흉터가 적고, 출혈이 적습니다. 따라서 세계 시장은 예측 기간 동안 이러한 변수에 의해 주도될 것으로 예상됩니다. 따라서 앞서 언급한 요인들이 2024-2030년의 예측 기간 동안 소화관 내시경 협착 관리 장비의 전체 시장을 견인할 것입니다.

그러나 관리 장비 및 수술과 관련된 부작용, 외과 수술 관련 부작용, 수술할 의료진 부족 등이 소화관 내시경 협착 관리 장비 시장의 성장을 저해할 수 있습니다.

위장관 내시경 협착 관리 기기 시장은 코로나19 팬데믹 기간 동안 큰 영향을 받았습니다. 코로나19 사태로 인해 외래 진료가 취소되고 긴급하지 않은 입원, 진단 및 수술이 중단되었기 때문입니다. 그 결과 정기적인 임상 검사, 진단 및 수술이 감소했습니다. 그러나 코로나19 백신 개발로 인해 봉쇄령이 완화되고 경제 상황이 정상화되면서 진단 및 치료를 위한 외래 진료 등 정상적인 의료 서비스가 재개되면서 소화기 내시경적 협착 관리 기기 시장의 제품 수요가 회복되고 있습니다.

위장관 내시경 협착증 관리 기기 시장 부문 분석

소화관 내시경 협착 관리 기기 시장의 유형별 부문에서 생식 건강 부문은 2023년 큰 매출 점유율을 차지할 것으로 예측됩니다. 이는 전 세계적으로 소화기 질환의 유병률 증가와 스텐트가 제공하는 이점 때문인 것으로 추정됩니다. 스텐트는 위장관의 막힘으로 인한 막힌 부분을 뚫어주는 데 사용되는 유연하고 자가팽창이 가능한 중공 금속 또는 플라스틱 튜브를 말합니다.

이 보고서는 세계 소화관 내시경 협착 관리 기기 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등의 정보를 전해드립니다.

목차

제1장 소화관 내시경 협착 관리 기기 시장 보고서 서론

제2장 소화관 내시경 협착 관리 기기 시장 주요 요약

  • 조사 범위
  • 시장 개요
  • 경쟁 평가

제3장 규제 분석

  • 미국
  • 유럽
  • 일본
  • 중국

제4장 소화관 내시경 협착 관리 기기 시장의 주요 요인 분석

  • 소화관 내시경 협착 관리 기기 시장 성장 촉진요인
  • 소화관 내시경 협착 관리 기기 시장 성장 억제요인과 과제
  • 소화관 내시경 협착 관리 기기 시장 기회

제5장 소화관 내시경 협착 관리 기기 시장 : Porter의 Five Forces 분석

제6장 소화관 내시경 협착 관리 기기 시장 레이아웃

  • 유형별
    • 풍선 확장기
    • 스텐트
    • Bougie Dilator
    • 기타
  • 최종사용자별
    • 병원 및 진료소
    • 외래수술센터(ASC)
  • 지역별
    • 북미의 소화관 내시경 협착 관리 기기 시장 규모(2021년-2030년)
    • 유럽의 소화관 내시경 협착 관리 기기 시장 규모(2021년-2030년)
    • 아시아태평양의 소화관 내시경 협착 관리 기기 시장 규모(2021년-2030년)
    • 기타 지역의 소화관 내시경 협착 관리 기기 시장 규모(2021년-2030년)

제7장 소화관 내시경 협착 관리 기기 시장 기업과 제품 개요

  • Boston Scientific Corporation
  • Cook
  • Olympus
  • HOBBS MEDICAL INC.
  • Merit Medical Systems
  • CONMED Corporation
  • Medi-Globe GmbH
  • Teleflex Incorporated
  • Ovesco Endoscopy AG
  • Richard Wolf GmbH
  • ZAVATION
  • Laborie.
  • Micro-Tech Endoscopy

제8장 KOL(Key Opinion Leader)의 견해

제9장 프로젝트 접근

제10장 DelveInsight에 대해

제11장 면책사항과 문의

LSH 24.03.25

Gastrointestinal Endoscopic Stricture Management Device Market By Type (Balloon Dilator, Stents, Bougie Dilator, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of various gastrointestinal disorders and the surging demand of minimally invasive treatment approach across the globe

The global gastrointestinal endoscopic stricture management device market is estimated to grow at a CAGR of 5.36% during the forecast period from 2024 to 2030. The demand for gastrointestinal endoscopic stricture management devices is being boosted by the increasing prevalence of various gastrointestinal (GI) disorders such as colon cancer, rectal cancer, esophageal cancer, gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), and other. Further, the rising demand for minimally invasive treatment devices, rising figures of GI disorder-causing risk factors, surging geriatric population base, technological advancements about the device, and rising product approvals and launches, among others are thereby contributing to the overall growth of the gastrointestinal endoscopic stricture management device market during the forecast period from 2024-2030.

Gastrointestinal Endoscopic Stricture Management Device Market Dynamics:

As per GLOBOCAN 2021, in 2020, nearly 604,100 new cases of oesophageal cancer were reported globally. The same source stated that in 2020, 1,089,103 new cases of stomach cancer and 115,949 new cases of biliary cancer were reported, globally.

In addition, various studies show that in palliative and neoadjuvant settings, stenting, a type of gastrointestinal endoscopic stricture management device is crucial in alleviating esophageal, gastroduodenal, or colorectal obstruction symptoms. Thus, the endoscopic insertion of self-expanding metal stents (SEMSs) has a frontline application for managing malignant obstruction or stricture of the gastrointestinal tract (GIT) driving the market growth.

Further, the latest study provided by International Foundation for Gastrointestinal Disorders, estimated that irritable bowel syndrome (IBS) affects 5-10% of the worldwide population. Most persons with IBS are under the age of 50. Also, about 2 in 3 IBS sufferers are female and about 1 in 3 IBS sufferers are male. The increasing prevalence of IBS can lead to stricture damage which can be treated by gastrointestinal endoscopic stricture management devices.

Therefore, the increasing prevalence of various GI disorders will lead to stricture damage, ultimately increasing the demand for gastrointestinal endoscopic stricture management devices, thereby driving the market for gastrointestinal endoscopic stricture management devices during the forecast period.

Also, stents and dilation devices effectively dilate and protect the gastrointestinal wall. The low complication rates and great technical success of these devices improve patient quality of life. These gadgets also function as successful alternatives to invasive procedures. When compared to traditional surgeries, minimally invasive procedures use cutting-edge technology to access internal organs through tiny incisions, resulting in less pain, a low risk of infection, a shorter hospital stay, a speedier recovery, less scarring, and less blood loss. Thus, the global market is probably going to be driven by these variables during the forecast period. Therefore, the aforementioned factors will propel the overall market of gastrointestinal endoscopic stricture management devices during the forecast period from 2024-2030.

However, side effects related to management devices or surgical procedures, scarcity of healthcare experts to perform surgical procedures, and others may restrict the gastrointestinal endoscopic stricture management device market growth.

The gastrointestinal endoscopic stricture management device market was significantly impacted during the period of COVID- 19 pandemic as the outbreak led to the cancellation of outpatient visits and the suspension of non-emergency hospitalization, diagnostic, and surgical procedures. This resulted in a reduced number of routine clinical examinations, diagnoses, and surgical procedures. However, the vaccine development of COVID-19 has initiated the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape which has initiated the process of resumption of regular healthcare services such as outpatients visits for diagnosis and treatment purposes, thereby bringing the demand for products on track in the gastrointestinal endoscopic stricture management device market.

Gastrointestinal Endoscopic Stricture Management Device Market Segment Analysis:

Gastrointestinal endoscopic stricture management device market by Type (Balloon Dilator, Stents, Bougie Dilator, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment of the gastrointestinal endoscopic stricture management device market, the reproductive health category is expected to amass a significant revenue share in the year 2023. This can be attributed to the increasing prevalence of GI diseases globally and the advantages the stents provide. A stent is a flexible, self-expandable, hollow metal or plastic tube used to help open any obstruction in the gastrointestinal (GI) tract that is blocked because of any clog formation.

Corrosive upper gastrointestinal strictures (GIS) are common in children, and primarily accidental ingestion, commonly in younger children, contributes to the GIS. In these cases, stents are used. According to various research, resistant caustic strictures are the most common indication of stent placement in children. In most cases, stents can be utilized along with endoscopic dilatation.

Further, the technological advancements in the stents for better outcomes are anticipated to contribute to the segment's growth. For instance, in February 2022, Micro-Tech Endoscopy introduced the first self-expanding tracheobronchial nitinol y-stent. The Y-Shaped Tracheal Stent System's nitinol self-expanding construction and simplicity of use make it efficient at relieving patients with malignant tracheobronchial strictures.

Therefore, the aforementioned factors are predicted to contribute to the increasing demand for this segment thereby driving the growth of the overall gastrointestinal endoscopic stricture management device market during the forecast period.

North America is expected to dominate the overall Gastrointestinal Endoscopic Stricture Management Device Market:

Among all the regions, North America is estimated to account for the largest share of the global gastrointestinal endoscopic stricture management device market in the year 2023. Owing to the factors such as the rising prevalence of gastrointestinal (GI) diseases which lead to increased research & development and manufacturing of numerous devices in the region. Furthermore, high disposable income, sophisticated healthcare infrastructure, and high awareness also helped the market growth in the country.

As per the 2023 report of the American Cancer Society, 106,970 new cases of colon cancer and 46,0850 new cases of rectal cancer are expected to be diagnosed in 2023. Also, as per the same source, about 21,560 new esophageal cancer cases will be diagnosed (17,030 in men and 4,530 in women), in the US, in 2023.

In addition, as per the 2021 report of the International Foundation for Gastrointestinal Disorders (IFFGD), 25 to 45 million people were affected by irritable bowel syndrome in the United States, in 2021.

These gastrointestinal diseases are responsible for strictures in the GI tract, creating the availability of stricture management devices. As gastrointestinal endoscopic stricture management devices, such as balloon dilators, stents, and bougie dilators, provide better outcomes, the need for such devices is increasing in the United States.

Coupled with the factors mentioned above, strategic activities such as product launches and approvals, mergers, acquisitions, partnerships, investments, and others also help in boosting regional product demand. For instance, in February 2022, Micro-Tech Endoscopy, a US-based manufacturer, introduced the first self-expanding tracheobronchial nitinol y-stent. The Y-Shaped Tracheal Stent System's nitinol self-expanding construction and simplicity of use make it efficient at relieving patients with malignant tracheobronchial strictures. Thus, such strategic steps help to increase the demand for gastrointestinal endoscopic stricture management devices, thereby driving the North America gastrointestinal endoscopic stricture management device market forward during the forecast period.

Gastrointestinal Endoscopic Stricture Management Device Market Key Players:

Some of the key market players operating in the gastrointestinal endoscopic stricture management device market include Boston Scientific Corporation, Cook, Olympus, HOBBS MEDICAL INC., Merit Medical Systems, CONMED Corporation, Medi-Globe GmbH, Teleflex Incorporated, Ovesco Endoscopy AG, Richard Wolf GmbH, ZAVATION, Laborie., Micro-Tech Endoscopy, and others.

Recent Developmental Activities in the Gastrointestinal Endoscopic Stricture Management Device Market:

In June 2022, Boston Scientific Corporation entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake (approximately 64%) of M.I.Tech Co., Ltd, a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures. M.I.Tech is the creator of the HANAROSTENT technology, a family of conformable, non-vascular, self-expanding metal stents, which Boston Scientific has distributed in Japan since 2015.

In October 2021, Boston Scientific Corporation received 510(k) clearance from the U.S. Food and Drug Administration and CE Mark approval to market its Advanix(TM) Biliary Plastic Stents for the treatment of biliary strictures, including biliary stone disease, benign biliary strictures, and suspected and confirmed malignancies in the biliary system.

Key Takeaways from the Gastrointestinal Endoscopic Stricture Management Device Market Report Study

Market size analysis for current gastrointestinal endoscopic stricture management device market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global gastrointestinal endoscopic stricture management device market.

Various opportunities available for the other competitor in the gastrointestinal endoscopic stricture management device market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current gastrointestinal endoscopic stricture management device market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for gastrointestinal endoscopic stricture management device market growth in the coming future?

Target Audience who can be benefited from this Gastrointestinal Endoscopic Stricture Management Device Market Report Study

Gastrointestinal endoscopic stricture management device products providers

Research organizations and consulting companies

Gastrointestinal endoscopic stricture management device-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in the gastrointestinal endoscopic stricture management device

Various End-users who want to know more about the gastrointestinal endoscopic stricture management device market and the latest technological developments in the gastrointestinal endoscopic stricture management device market.

Frequently Asked Questions for the Gastrointestinal Endoscopic Stricture Management Device Market:

1. What is a gastrointestinal endoscopic stricture management device?

Gastrointestinal endoscopic stricture refers to an abnormal narrowing or blocking of sections of the GI tract due to the presence of a tumor or a scar. These strictures are usually treated with endoscopy, a minimally invasive medical method to investigate and operate procedures without making large incisions with the help of various dilation devices and stents.

2. What is the market for global gastrointestinal endoscopic stricture management devices?

The global gastrointestinal endoscopic stricture management device market is estimated to grow at a CAGR of 5.36% during the forecast period from 2024 to 2030.

3. What are the drivers for the global gastrointestinal endoscopic stricture management device market?

The demand for gastrointestinal endoscopic stricture management devices is primarily being heightened by the surging statistics of various GI disorders, increasing risk factors, increasing preference for minimally invasive procedures, rising geriatric population associated with disturbances in esophageal motility and a decreased production of saliva, surging product approvals and launches, among others, thereby contribute to the overall growth of the gastrointestinal endoscopic stricture management device market during the forecast period from 2024-2030.

4. Who are the key players operating in the global gastrointestinal endoscopic stricture management device market?

Some of the key market players operating in the gastrointestinal endoscopic stricture management device market include Boston Scientific Corporation, Cook, Olympus, HOBBS MEDICAL INC., Merit Medical Systems, CONMED Corporation, Medi-Globe GmbH, Teleflex Incorporated, Ovesco Endoscopy AG, Richard Wolf GmbH, ZAVATION, Laborie., Micro-Tech Endoscopy, and others.

5. Which region has the highest share in the gastrointestinal endoscopic stricture management device market?

North America is expected to dominate the overall gastrointestinal endoscopic stricture management device market during the forecast period from 2024-2030. Factors such as the rising prevalence of GI disorders, increasing geriatric population, and rising demand for minimally invasive treatment approaches, among the target population, among others will positively impact the North American gastrointestinal endoscopic stricture management device market. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about GI disorders also helped the market growth in this region.

Table of Contents

1.Gastrointestinal Endoscopic Stricture Management Device Market Report Introduction

2. Gastrointestinal Endoscopic Stricture Management Device Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Gastrointestinal Endoscopic Stricture Management Device Market Key Factors Analysis

  • 4.1. Gastrointestinal Endoscopic Stricture Management Device Market Drivers
    • 4.1.1. Rising prevalence of GI disorders
    • 4.1.2. Increasing preference for minimally invasive procedures
    • 4.1.3. The rising geriatric population is associated with disturbances in esophageal motility and a decreased production of saliva
  • 4.2. Gastrointestinal Endoscopic Stricture Management Device Market Restraints and Challenges
    • 4.2.1. Side effects related to management devices or surgical procedures
    • 4.2.2. Scarcity of healthcare experts to perform surgical procedures
  • 4.3. Gastrointestinal Endoscopic Stricture Management Device Market Opportunities
    • 4.3.1. Increasing technological advantages such as self-expanding nitinol stent among other

5. Gastrointestinal Endoscopic Stricture Management Device Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Gastrointestinal Endoscopic Stricture Management Device Market Layout

  • 6.1. By Type
    • 6.1.1. Balloon Dilator
    • 6.1.2. Stents
    • 6.1.3. Bougie Dilator
    • 6.1.4. Others
  • 6.2. By End-User
    • 6.2.1. Hospitals & Clinics
    • 6.2.2. Ambulatory Surgical Centers
    • 6.2.3. Others
  • 6.3. By Geography
    • 6.3.1. North America Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
      • 6.3.1.1. United States Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
      • 6.3.1.2. Canada Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
      • 6.3.1.3. Mexico Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.2. Europe Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
      • 6.3.2.1. France Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
      • 6.3.2.2. Germany Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
      • 6.3.2.3. United Kingdom Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
      • 6.3.2.4. Italy Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
      • 6.3.2.5. Spain Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
      • 6.3.2.6. Rest of Europe Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.3. Asia-Pacific Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
      • 6.3.3.1. China Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
      • 6.3.3.2. Japan Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
      • 6.3.3.3. India Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
      • 6.3.3.4. Australia Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
      • 6.3.3.5. South Korea Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
      • 6.3.3.6. Rest of the Asia-Pacific Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.4. Rest of the World (RoW) Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
      • 6.3.4.1. Middle East Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
      • 6.3.4.2. Africa Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
      • 6.3.4.3. South America Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)

7. Gastrointestinal Endoscopic Stricture Management Device Market Company and Product Profiles

  • 7.1. Boston Scientific Corporation
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Cook
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Olympus
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. HOBBS MEDICAL INC.
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Merit Medical Systems
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. CONMED Corporation
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Medi-Globe GmbH
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Teleflex Incorporated
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Ovesco Endoscopy AG
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Richard Wolf GmbH
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. ZAVATION
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Laborie.
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Micro-Tech Endoscopy
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제